Literature DB >> 7963341

Shigellosis in Calcutta during 1990-1992: antibiotic susceptibility pattern and clinical features.

M K Bhattacharya1, S K Bhattacharya, M Paul, D Dutta, P Dutta, H Kole, D De, A R Ghosh, P Das, G B Nair.   

Abstract

Of 230 cases of bloody diarrhoea studied, 100 (43.5%) were positive for Shigellae by stool culture, of which Shigella dysenteriae type 1 was isolated from 56 cases, S. flexneri from 35, S. boydii from 5 and S. sonnei from 4. The major clinical manifestations of the patients infected with Shigella spp. were abdominal pain, anorexia, vomiting, tenesmus, and fever. Fever of above 100.5 degrees F and frequency of stool of more than 15 per day were noticed more among cases infected with S. dysenteriae type 1 and S. flexneri. Vomiting was more frequently observed in cases infected with S. sonnei or S. boydii (44.4%) as compared to those infected with S. dysenteriae type 1 (10.7%) and S. flexneri (8.6%). All Shigella isolates were uniformly susceptible to norfloxacin and ciprofloxacin but were resistant to streptomycin. S. dysenteriae type 1 isolates were susceptible to nalidixic acid (69.6%), ampicillin (5.4%), TMP-SMX (12.5%), furazolidone (98.2%) and gentamycin (80.4%), whereas all other Shigella isolates (S. flexneri, S. boydii, and S. sonnei) were uniformly susceptible to nalidixic acid, > 94% susceptible to furazolidone, and only moderately susceptible to ampicillin (28.6% to 55.5%) and TMP-SMX (22.2% to 48.6%).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963341

Source DB:  PubMed          Journal:  J Diarrhoeal Dis Res        ISSN: 0253-8768


  2 in total

1.  Serotypes and antimicrobial susceptibility patterns of Shigella species isolated from children in Calcutta, India.

Authors:  S Dutta; T Sinha Mahapatra; P Dutta; U Mitra; S Dasgupta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

2.  Shigella dysenteriae serotype 1, Kolkata, India.

Authors:  Shanta Dutta; Sharitri Dutta; Phalguni Dutta; Shigeru Matsushita; Sujit Kumar Bhattacharya; Shin-ichi Yoshida
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.